OASMIA PHARMACEUTICAL
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.
OASMIA PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1990-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.oasmia.com
Total Employee:
51+
Status:
Active
Contact:
46 18 50 54 40
Email Addresses:
[email protected]
Total Funding:
36.95 M USD
Technology used in webpage:
SPF SSL By Default Apple Mobile Web Clips Icon Wordpress Plugins Amazon Microsoft Azure DNS Network Solutions DNS Browse Happy Zendesk Twitter CDN
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Yorkville Advisors
Yorkville Advisors investment in Post-IPO Equity - Oasmia Pharmaceutical
Official Site Inspections
http://www.oasmia.com
- Host name: 46.253.206.129
- IP address: 46.253.206.129
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
